Clinical trials are especially meaningful when they represent the full diversity of the populations they aim to serve.

OpenAI and Google are currently locked in the race to offer the best Deep Research agent. Gemini’s Deep Research agent is powered by the new Gemini 2.0 Flash Thinking model whereas ChatGPT’s Deep ...

Shardul Amarchand Mangaldas & Co (SAM) and JSA are advising Veeda Clinical Research Limited on its proposed IPO, comprising a ₹185 crore fresh issue and an offer for sale of up to 13,008,128 equity ...

Clinical research organisation Veeda Clinical Research has re-filed preliminary papers with markets regulator SEBI seeking its approval to raise funds through an initial share sale. The Gujarat-based ...

Veeda Clinical Research: Veeda Clinical Research has refiled its IPO papers with SEBI, planning to raise funds through a fresh issue and offer-for-sale. The proceeds will support capital expenditure, ...

CX Partners backed Veeda Clinical Research, a full-service contract research organization (CRO) has refiled its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and ...

IPO Watch: Veeda Clinical Research has refiled its draft prospectus for an IPO with SEBI, seeking to raise ₹185 crore. (Image: Pixabay) IPO Watch: Veeda Clinical Research has refiled its draft ...

Veeda’s total addressable market (TAM) is projected to grow from $65.4 billion (Rs 5.7 trillion) in 2023 to $110.7 billion (Rs 9.65 trillion) by 2028, reflecting a compound annual growth rate ...

That infinity-inspired design seems to reflect that of Heads, the European CRO that Veeda Clinical Research acquired in the spring of 2024 and which expanded its footprint across Europe ...

and Preclinical & Non-Clinical Testing Services, making Veeda an integrated research service provider. Veeda Lifesciences represents the brand that integrates Veeda Clinical Research, Health Data ...